aTyr Pharma, Inc.
ATYR
$0.53
-$0.03-5.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.79M | -13.96M | -25.74M | -19.53M | -14.88M |
| Total Depreciation and Amortization | 394.00K | 394.00K | 389.00K | 387.00K | 383.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.05M | 833.00K | 793.00K | 846.00K | 654.00K |
| Change in Net Operating Assets | -3.17M | 540.00K | 4.09M | 4.40M | -1.58M |
| Cash from Operations | -12.52M | -12.20M | -20.48M | -13.89M | -15.42M |
| Capital Expenditure | -138.00K | -31.00K | -37.00K | -9.00K | -- |
| Sale of Property, Plant, and Equipment | -- | 12.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.63M | 16.46M | -20.34M | 3.31M | -4.42M |
| Cash from Investing | 11.49M | 16.44M | -20.38M | 3.30M | -4.42M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -142.00K | -139.00K | -136.00K | -133.00K | -131.00K |
| Issuance of Common Stock | -- | 8.00K | 29.75M | 18.03M | 18.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -142.00K | -131.00K | 29.62M | 17.90M | 18.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.17M | 4.12M | -11.24M | 7.30M | -1.21M |